Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review.
Amine SaouliA TouzaniA MartiniJ B BeauvalH DergamounI ZiouziouN DeffarG PloussardA OuzzanePublished in: Prostate cancer and prostatic diseases (2023)
Similar to published studies, RP of oligometastatic PCa appears to be safe with acceptable morbidity in selected patients. The lack of a consensual definition, the low level of evidence and the bias of the comparative and retrospective studies available do not allow practical recommendations to be made. There is currently no place for metastatic surgery outside of participation in a clinical trial.
Keyphrases
- radical prostatectomy
- prostate cancer
- clinical trial
- end stage renal disease
- newly diagnosed
- minimally invasive
- ejection fraction
- chronic kidney disease
- squamous cell carcinoma
- case control
- prognostic factors
- physical activity
- peritoneal dialysis
- coronary artery bypass
- coronary artery disease
- systematic review
- study protocol
- open label
- clinical practice
- cross sectional
- acute coronary syndrome
- meta analyses